N88D Facilitates the Co-occurrence of D30N and L90M and the Development of Multidrug Resistance in HIV Type 1 Protease following Nelfinavir Treatment Failure

Documenti analoghi

• HIV-1 Drug Resistance Genotype Results in Patients With Plasma Samples With HIV-1 RNA Levels Less Than 75 Copies/mL
  di: Mitsuya, Yumi, et al.
  Pubblicazione: (2006)
• Prevalence of Darunavir Resistance-Associated Mutations: Patterns of Occurrence and Association with Past Treatment
  di: Mitsuya, Yumi, et al.
  Pubblicazione: (2007)
• Association of a Novel Human Immunodeficiency Virus Type 1 Protease Substrate Cleft Mutation, L23I, with Protease Inhibitor Therapy and In Vitro Drug Resistance
  di: Johnston, Elizabeth, et al.
  Pubblicazione: (2004)
• HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance
  di: Kolli, Madhavi, et al.
  Pubblicazione: (2014)
• HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance
  di: Rhee, Soo-Yon, et al.
  Pubblicazione: (2005)